Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

A Study Suggests That Tumors With p53 Mutations Could Be Shrunk by Starvation

A Study Suggests That Tumors With p53 Mutations Could Be Shrunk by Starvation

One characteristic of cancer cells is their ability to adapt to difficult conditions such as nutrient deprivation. Constantly and rapidly growing tumor cells must compete for diminishing nutrients to survive and multiply. Targeting these adaptation mechanisms is an important approach in cancer therapeutics. Researchers at Sanford Prebys Medical Discovery Institute identified an alternative pathway cancer cells may use to survive without nutrients. Molecular Cell published the study, which found that PI5P4K enzyme family proteins PI5P4Kα and PI5P4Kβ are important for autophagy , a cellular process.

- Related Topic: Yoshinori Ohsumi Awarded the 2016 Nobel Prize in Medicine for Autophagy Research

Autophagy recycles cellular products to provide nutrients for starving cells. The authors suggest that targeting these proteins to disrupt autophagy in cancer cells could be an exciting treatment strategy. Researcher Brooke Emerling explains: “The importance of this alternative pathway was mysterious until these enzymes were discovered 20 years ago by the Lewis Cantley laboratory. Our research identifies a distinctive regulatory step in autophagy and sheds light on the anticancer potential of PI5P4K inhibitors.”

How Cells Cope With Metabolic Stress

Nutrient-deprived cells can maintain energy by shrinking or recycling unnecessary or damaged components. This survival mechanism, called autophagy, also contributes to growth and aging and is known to play roles in neurodegenerative diseases, skeletal muscle myopathy, heart disease, liver disease, and cancer. Autophagy is therefore a double-edged sword . During autophagy, abnormal molecules or damaged organisms are first drawn into vesicles called autophagosomes. Controlled autophagy is essential for life, yet little is known about the signaling molecules governing it. The new research found that the PI5P4K enzyme family, whose function during metabolic stress was previously unknown, plays an important role. Genetically silencing Pip4k2a and Pip4k2b, the pathway’s most active enzymes, disrupted autophagy in starving cancer cells lacking the tumor-suppressing p53 protein .

- Related Topic: What Are the TP53 Gene and p53 Protein? What Does TP53 Mutation Positivity Mean in Cancer?

The p53 protein protects against tumor formation and is absent in more than half of human cancers because of p53 gene mutations. This research suggests that inhibiting enzymes involved in autophagy could provide effective treatment for p53 mutation-positive tumors. Despite the prevalence of p53 mutations in cancer, no medicine targeting this alteration has yet been developed.

Starving Tumors

In a 2013 Cell study, Emerling and Cantley identified a breast cancer subgroup with high PI5P4Kα and PI5P4Kβ levels. They also showed these enzymes were essential for the growth of p53-deficient breast cancer cells. Meanwhile, Pip4k2a and Pip4k2b deficiency reduced tumor development and provided effective cancer treatment in p53-deficient mice. At the time, how PI5P4Ks supported p53-deficient cell growth remained unknown.

The new research sheds light on this question. These enzymes are thought to enhance cancer cells’ ability to adapt to a nutrient-poor tumor microenvironment.

According to these studies, PI5P4K inhibitors may treat p53-mutated cancers by interfering with autophagy.

Further research is needed to understand PI5P4Ks and their relationship with p53 in tumor metabolism. Emerling’s laboratory is focusing on PI5P4K enzymes in p53-deficient cancer cells, particularly in triple-negative breast cancer, where effective treatment options are limited.

Emerling concludes: “We know that enzymes involved in autophagy are vulnerable to medicines. By targeting them with specific compounds, we may develop successful treatments for cancer and conditions associated with autophagy.”

Sources

Mark R. Lundquist, Marcus D. Goncalves, Ryan M. Loughran, Arnim Pause, Lewis C. Cantley, Brooke M. Emerling.
Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.
Molecular Cell, May 2018.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

A Study Suggests That Tumors With p53 Mutations Could Be Shrunk by Starvation

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy